Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease
Authors:
- Dorothea ReussDRDorothea Reuss
- Bettina Götze-SpeerBGBettina Götze-Speer
- Christian P. SpeerCSChristian P. Speer
- 1 June 1993
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 122 (6) , 938-944
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasiaThe Journal of Pediatrics, 1992
- Differential effects of oxygen and barotrauma on lung injury in the neonatal pigletPediatric Pulmonology, 1991
- Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: A controlled trialThe Journal of Pediatrics, 1989
- A Controlled Trial of Dexamethasone in Preterm Infants at High Risk for Bronchopulmonary DysplasiaNew England Journal of Medicine, 1989
- Effects of dexamethasone and indomethacin on elastase, α1-proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonatesThe Journal of Pediatrics, 1988
- Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.Journal of Clinical Investigation, 1987
- Elastase-α1-proteinase inhibitor in early diagnosis of neonatal septicemiaThe Journal of Pediatrics, 1986
- Pulmonary Epithelial Permeability in Hyaline-Membrane DiseaseNew England Journal of Medicine, 1984
- Pulmonary Oxygen ToxicityNew England Journal of Medicine, 1983
- Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia.Journal of Clinical Investigation, 1983